ARKDARK DIET Q1 Buffer ETF
Seeks capital appreciation with a measure of downside protection over a 12-month Outcome Period.
By ARK ETF Trust · Launched 2026
0.89%
#4,486 of 5,562 · expensive
$2M
#5,386 of 5,562 · small
N/A
5 months
#5,147 of 5,562 · young
Performance
Total-return NAV · USDTotal-return NAV, USD. Net of fund fees, before tax.
Classification
How Beacon categorizes this fundAsset class
AlternativeStrategy
Structured outcome
What it actually holds
By weightConcentration
Top 5 holdings = 100.0% of fundconcentrated
Asset allocation
Risk profile
Last 12 months · Sharpe & Sortino need 3+ yearsWorst peak-to-trough loss
Needs 3+ years of history
Needs 3+ years of history
Where to buy
Listing
- Exchange
- Cboe BZX
Full fund details
- Objective
- Seeks capital appreciation with a measure of downside protection over a 12-month Outcome Period.
- Strategy
- Defined-outcome buffer ETF holding the ARK Innovation ETF (ARKK) as a delta-one position, overlaid with FLEX options (written at-the-money calls, purchased at-the-money puts on 50% of NAV, purchased out-of-the-money calls struck at 105%). Targets uncapped upside above a 5% hurdle on ARKK and a 50% downside participation offset over each 12-month Outcome Period (January 1 to December 31). Outcomes realized only by holding from the first to last day of the Outcome Period.
- Inception date
- January 2, 2026
- Fund family
- ARK ETF Trust
Similar ETFs
Closest matches by profileOur take
Structural notes on how this fund behaves. Read our guide on the 6 warning signs.
Buffer ETF — downside protection at a cost
Defined-outcome funds cap upside (typically 8–20%) in exchange for partial downside protection (9–30%), priced via options. Fees are materially higher than the underlying index (often 0.70%+ vs 0.03–0.10%). For most pre-retirees, a simple stock/bond mix achieves similar downside behaviour at a fraction of the cost.
Source: Morningstar, 'Defined-Outcome ETFs: Useful or Uneconomic?' (2023)
Why we flagged this: strategy=structured_outcome + structured_outcome_strategy
Educational analysis of structural product characteristics. Not investment advice. Always read the fund prospectus and consult a qualified advisor before investing. More
What's next?
You've reviewed ARKD. Save it to your watchlist to track it alongside the other funds you're weighing.
Data updated on 2026-06-19